Immediate Impact
17 standout
Citing Papers
Multidrug-resistant tuberculosis
2024 Standout
Antimicrobial peptides: Opportunities and challenges in overcoming resistance
2024 Standout
Works of Roeland E. Wasmann being referenced
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study
2021
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Roeland E. Wasmann | 224 | 75 | 161 | 122 | 40 | 383 | |
| Cornelis Smit | 120 | 88 | 171 | 76 | 22 | 409 | |
| Kim C. M. van der Elst | 272 | 30 | 122 | 181 | 24 | 414 | |
| Ruth Van Daele | 193 | 23 | 172 | 171 | 20 | 376 | |
| Christophe Padoin | 102 | 31 | 228 | 120 | 21 | 424 | |
| Kai van Hateren | 171 | 38 | 158 | 103 | 20 | 388 | |
| Frank Kloprogge | 130 | 122 | 83 | 85 | 31 | 426 | |
| Philip M. Colangelo | 215 | 46 | 77 | 180 | 13 | 351 | |
| F. Borsa-Lebas | 133 | 32 | 119 | 102 | 21 | 364 | |
| Gordon Brier | 118 | 40 | 218 | 106 | 19 | 392 | |
| Mary L. Townsend | 190 | 15 | 70 | 157 | 28 | 362 |
All Works
Login with ORCID to disown or claim papers
Loading papers...